Predilife

ALPRE · PA · Healthcare / Diagnostics & Research

0.63EUR-0.12 (-16.00%)

Price History

Full chart

Market Stats

Previous Close0.75

Open0.63

Day Range0.63 – 0.63

52-Week Range0.90 – 4.00

Volume610

Market Cap3.60M

P/E (TTM)0.00

Forward P/E0.00

EPS-1.00

Dividend Yield0.00%

Beta0.24

50-Day Avg1.13

200-Day Avg2.44

About

Predilife S.A. designs and markets predictive tests for the occurrence of serious illnesses. The company provides breast cancer predictive assessment; multi-pathology predictive assessment; and the Care4Eat solution, a nutrition assessment that allows employees to take stock of their eating habits and benefit from rebalancing and personalized advice. It also offers MammoRisk, a breast cancer prediction test based on the patient's individual risk; and DenSeeMammo, a breast density measurement software. Predilife S.A. was incorporated in 2004 and is headquartered in Villejuif, France.

Company Details

SectorHealthcare
IndustryDiagnostics & Research
CEOMr. Stephane Ragusa
Employees20
Headquarters39 Rue Camille Desmoulins, Villejuif, France, 94805, France
Websitehttps://www.predilife.com

Leadership

Mr. Stephane RagusaFounder, President, CEO & Chairman · b. 1970
Mr. Émilien GauthierChief Technical Officer
Marion RenelierLegal Director & Data Protection Officer
Anne KerzanChief Marketing Officer

Financials

Income Statement

Currency: EUR	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Revenue	8	42.00K	72.26K	22.87K	51.57K	142.08K	288.60K	317.79K	618.06K	1.12M
Growth (%)	-	+524937.50%	+72.03%	-68.35%	+125.48%	+175.51%	+103.12%	+10.11%	+94.48%	+80.86%
Cost of Revenue	13.64K	14.33K	8.92K	1.16M	1.64M	2.10M	44.24K	14.64K	13.82K	12.75K
Gross Profit	-13.63K	27.67K	63.34K	-1.14M	-1.59M	-1.96M	244.36K	303.15K	604.24K	1.11M
Gross Margin	-170375.00%	65.87%	87.66%	-4977.54%	-3088.84%	-1376.76%	84.67%	95.39%	97.76%	98.86%
Operating Expense	1.58M	1.90M	2.42M	1.28M	894.26K	1.56M	3.75M	4.14M	4.59M	3.96M
Operating Income	-1.60M	-1.88M	-2.36M	-2.42M	-2.49M	-3.52M	-3.50M	-3.84M	-3.99M	-2.85M
Operating Margin	-19947312.50%	-4464.26%	-3259.79%	-10592.21%	-4822.89%	-2477.67%	-1214.16%	-1208.30%	-645.02%	-255.08%
EBITDA	-1.60M	-1.87M	-2.51M	-2.39M	-2.46M	-3.49M	-3.47M	-3.82M	-3.95M	-2.74M
EBITDA Margin	-20015462.50%	-4453.27%	-3478.01%	-10470.99%	-4778.32%	-2456.79%	-1203.10%	-1202.39%	-639.49%	-245.09%
Net Income	-1.49M	-1.65M	-2.37M	-2.10M	-2.25M	-3.41M	-3.65M	-4.22M	198.63M	-3.52M
Net Income Margin	-18563437.50%	-3940.09%	-3281.30%	-9191.15%	-4364.07%	-2402.69%	-1266.31%	-1329.20%	32137.35%	-315.27%
Interest Expense	17.28K	36.56K	70.44K	41.17K	44.04K	188.77K	300.69K	616.89K	867.75K	1.06M
Interest Expense % of Total Revenue	216037.50%	87.05%	97.48%	179.99%	85.40%	132.86%	104.19%	194.12%	140.40%	94.78%

Balance Sheet

Currency: EUR	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Assets	2.48M	1.01M	2.31M	1.35M	4.10M	3.97M	4.75M	8.82M	2.44M	1.83M
Total Liabilities	2.11M	2.30M	2.32M	2.11M	3.37M	5.53M	9.97M	8.30M	6.71M	8.75M
Total Equity	362.63K	-1.29M	-12.10K	-764.29K	721.69K	-1.57M	-5.22M	513.52K	-4.27M	-6.91M
Cash	1.74M	622.64K	1.49M	304.08K	3.15M	2.82M	3.73M	2.51M	1.06M	556.92K
Total Debt	2.12M	2.07M	1.55M	1.49M	2.74M	5.13M	7.34M	7.18M	4.95M	5.52M
Net Debt	158.06K	1.45M	60.83K	1.19M	-412.30K	2.31M	3.56M	4.67M	3.89M	4.97M

Cash Flow

Currency: EUR	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Operating Cash Flow	-1.36M	-1.53M	-1.81M	-2.39M	-2.11M	-3.83M	-3.07M	-4.23M	-3.72M	-2.56M
Investing Cash Flow	-86.74K	-41.26K	-188.08K	-51.10K	-33.67K	-10.63K	20.25K	-31.36K	-687.59K	40.46K
Financing Cash Flow	2.57M	175.43K	2.86M	1.26M	4.99M	3.51M	3.95M	3.05M	2.23M	2.02M
Capital Expenditure	56.74K	41.26K	188.08K	21.80K	15.68K	3.37K	26.99K	42.43K	5.39K	2.03K
Free Cash Flow	-1.41M	-1.57M	-2.00M	-2.42M	-2.12M	-3.83M	-3.09M	-4.27M	-3.73M	-2.57M
Dividends Paid	-	-	91.00K	215.00K	-	2.55M	1.55M	-	-	-
FCF to OCF	104.19%	102.70%	110.40%	100.91%	100.74%	100.09%	100.88%	101.00%	100.14%	100.08%
Dividend Paid to FCF	-	-	-4.56%	-8.90%	-	-66.57%	-50.11%	-	-	-

Earnings

Report Date	Dec 24, 2018	May 2, 2019	Oct 16, 2019	May 1, 2020	Oct 8, 2020	Jun 26, 2021	Oct 29, 2021	Apr 29, 2022	Oct 28, 2022	Apr 28, 2023	Oct 25, 2024	Jun 6, 2025	Oct 21, 2025
EPS Estimate	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EPS Actual	-0.29	-0.55	-0.43	-0.29	-0.30	-0.34	-0.53	-0.41	-0.45	-0.55	-0.64	-0.50	-0.50
Surprise	-	-	-	-	-	-	-	-	-	-	-	-	-
Timing	-	-	-	-	-	-	-	-	-	-	-	-	-

Key Statistics & Ratios

Market Cap3.60M

Enterprise Value8.60M

Trailing P/E0.00

Forward P/E0.00

Price / Sales4.31

Price / Book35.76

EPS-1.00

Book Value-4.15

Revenue (TTM)835.81K

Gross Profit (TTM)816.75K

EBITDA-3.25M

Profit Margin0.00%

Operating Margin-380.15%

Return on Equity0.00%

Return on Assets-95.48%

Shares Outstanding3.94M

Shares Float996.75K

Beta0.24

Dividend Yield0.00%

Dividend Rate0.00

Payout Ratio0.00%